Mark Hobeika
Overview
Explore the profile of Mark Hobeika including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knight R, Ye Y, Graviss E, Nguyen D, Garami Z, Yi S, et al.
Clin Transplant
. 2024 Jul;
38(7):e15413.
PMID: 39033508
Introduction: It is unclear whether kidney/pancreas (KP) transplantation will prevent the progression of peripheral arterial disease (PAD) in patients with insulin dependent diabetes (IDDM) and end-stage renal disease. We sought...
2.
Meinders A, Knight R, Eagar T, Hobeika M, Podder H, Gaber A, et al.
Clin Transplant
. 2023 Mar;
37(8):e14963.
PMID: 36938669
Introduction: In an effort to maximize living donor kidney utilization, we describe the use of deceased donor vein extension grafts for right-sided living donor kidneys and report our single-center experience...
3.
Yi S, Moore L, Eagar T, Graviss E, Nguyen D, Ibrahim H, et al.
Transplant Direct
. 2021 Dec;
8(1):e1257.
PMID: 34912946
Background: Data about vaccine efficacy in solid organ transplant patients are limited. We previously reported our initial observation of a 6.2% immunogenicity rate in kidney transplant recipients (KTRs) after administration...
4.
Cooper M, Dunne I, Kuten S, Curtis A, Graviss E, Nguyen D, et al.
Transplant Proc
. 2020 Nov;
53(3):984-988.
PMID: 33246588
Background: Human immunodeficiency virus (HIV)-positive kidney transplant (KT) recipients have been shown to experience higher rejection rates due in part to drug-drug interactions between antiretroviral therapy (ART) and immunosuppression regimens....
5.
Nolte Fong J, Saharia A, Hobeika M, Podder H, Ghobrial R
Liver Transpl
. 2020 Oct;
26(12):1568-1570.
PMID: 33029875
No abstract available.
6.
Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center
Yi S, Rogers A, Saharia A, Aoun M, Faour R, Abdelrahim M, et al.
Transplantation
. 2020 Jun;
104(11):2208-2214.
PMID: 32496357
Background: The novel coronavirus severe acute respiratory syndrome coronavirus 2 [coronavirus disease 2019 (COVID-19)] poses unique challenges for immunosuppressed patients. Solid organ transplant (SOT) recipients comprise a large proportion of...
7.
Rice T, Kassam A, Lewis H, Hobeika M, Cuffy M, Ratner L, et al.
J Surg Educ
. 2020 Feb;
77(4):830-836.
PMID: 32067900
Objective: Living kidney donation is a unique operation, as healthy patients are placed at risks inherent with major surgery without physical benefit. The ethical implications associated with any morbidity make...